Another important mechanism is the active targeting of nanocarriers to GBM cells through surface modifications, whose targets are cellular elements overexpressed in cancer cells (i.e.: transmembrane receptors, growth factors secreted by the cell, or even elements of the extracellular matrix of these tissues) (Fig. 4). Here, NRP1 is linked to glioblastoma.